Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial (vol 389, pg 1103, 2017)

Nemeth G.; Laszlovszky I; Czobar P.

首页> 外文期刊>The Lancet >Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial (vol 389, pg 1103, 2017)

【24h】

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial (vol 389, pg 1103, 2017)

机译：甲尿嘧啶与risperidone单一治疗精神分裂症患者的主要症状：随机，双盲，受控试验（Vol 389，PG 1103,2017）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《The Lancet》 |2017年第10074期|共1页
作者
Nemeth G.; Laszlovszky I; Czobar P.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial (vol 389, pg 1103, 2017) [J] . Nemeth G., Laszlovszky I, Czobar P. The Lancet . 2017,第10074期

机译：甲尿嘧啶与risperidone单一治疗精神分裂症患者的主要症状：随机，双盲，受控试验（Vol 389，PG 1103,2017）
2. L-carnosine as an add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: A double-blind, randomized placebo-controlled trial [J] . Ghajar Alireza, Khoaie-Ardakani Mohammad-Reza, Shahmoradi Zahara, Psychiatry research . 2018,第期

机译：L-肉毒藤作为稳定精神分裂症患者的阴性症状的丙酮酮：双盲，随机安慰剂对照试验
3. A double-blind, placebo controlled, randomized trial of riluzole as an adjunct to risperidone for treatment of negative symptoms in patients with chronic schizophrenia [J] . FarokhniaM., SabzabadiM., PourmahmoudH., Psychopharmacology . 2014,第3期

机译：利鲁唑作为利培酮的辅助治疗安慰剂对照的双盲，随机试验，用于治疗慢性精神分裂症患者的阴性症状
4. Efficacy of Zinc Sulfate as an Add-on Therapy to Risperidone Versus Risperidone Alone in Patients With Schizophrenia: A Double-Blind Randomized Placebo-Controlled Trial [O] . Mehran Mortazavi, Davood Farzin, Mehran Zarhghami, 2015

机译：硫酸锌作为利培酮与单独利培酮治疗精神分裂症的附加疗法：双盲随机安慰剂对照试验
5. Quality-adjusted life year difference in patients with predominant negative symptoms of schizophrenia treated with cariprazine and risperidone [O] . Bertalan Németh, Anett Molnár, Ron Akehurst, 2017

机译：用甲皮针和蓖麻素治疗精神分裂症的患者患者的质量调整的终身差异

Cariprazine versus risperidone monotherapy for treatment of predominant negative symptoms in patients with schizophrenia: a randomised, double-blind, controlled trial (vol 389, pg 1103, 2017)

著录项

相似文献

相关主题

期刊订阅